| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2024-04-09 | GOLDMAN SACHS GROUP INC | Vincerx Pharma, Inc. | 631,490 | 3.0% | EDGAR |
| SC 13G | 2024-03-11 | GOLDMAN SACHS GROUP INC | MorphoSys AG | 4,141,089 | 10.8% | EDGAR |
| SC 13G/A | 2024-03-05 | GOLDMAN SACHS GROUP INC | D-Wave Quantum Inc. | 2,140,091 | 1.9% | EDGAR |
| SC 13G/A | 2024-02-16 | GOLDMAN SACHS GROUP INC | D-Wave Quantum Inc. | 7,939,415 | 7.0% | EDGAR |
| SC 13G/A | 2024-02-14 | GOLDMAN SACHS GROUP INC | D-Wave Quantum Inc. | 7,939,415 | 5.0% | EDGAR |
| SC 13G/A | 2024-02-13 | GOLDMAN SACHS GROUP INC | ZimVie Inc. | 87,588 | 0.3% | EDGAR |
| SC 13G/A | 2024-02-13 | GOLDMAN SACHS GROUP INC | ELDORADO GOLD CORP /FI | 9,649,321 | 4.7% | EDGAR |
| SC 13G/A | 2024-02-13 | GOLDMAN SACHS GROUP INC | Privia Health Group, Inc. | 41,373 | 0.0% | EDGAR |
| SC 13G/A | 2024-02-13 | GOLDMAN SACHS GROUP INC | MIDDLEBY Corp | 531,229 | 1.0% | EDGAR |
| SC 13G/A | 2024-02-13 | GOLDMAN SACHS GROUP INC | Innovid Corp. | 189,382 | 0.1% | EDGAR |
| SC 13G/A | 2024-02-13 | GOLDMAN SACHS GROUP INC | Perfect Corp. | 11,079,576 | 10.9% | EDGAR |
| SC 13G/A | 2024-02-13 | GOLDMAN SACHS GROUP INC | Spring Valley Acquisition Corp. II | 722,419 | 3.1% | EDGAR |
| SC 13G/A | 2024-02-13 | - | - | - | - | EDGAR |
| SC 13G/A | 2024-02-13 | GOLDMAN SACHS GROUP INC | Sterling Check Corp. | 49,809,136 | 52.8% | EDGAR |
| SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | GOLDMAN SACHS GROUP INC | 28,546,582 | 8.8% | EDGAR |
| SC 13G | 2024-02-13 | GOLDMAN SACHS GROUP INC | Nukkleus Inc. | 140,445 | 7.2% | EDGAR |
| SC 13G/A | 2024-02-12 | GOLDMAN SACHS GROUP INC | Silence Therapeutics plc | 2,316,169 | 2.2% | EDGAR |
| SC 13G/A | 2024-02-12 | GOLDMAN SACHS GROUP INC | CSLM ACQUISITION CORP. | 220 | 0.0% | EDGAR |
| SC 13G | 2024-02-12 | GOLDMAN SACHS GROUP INC | WINNEBAGO INDUSTRIES INC | 1,756,336 | 6.0% | EDGAR |
| SC 13G | 2024-02-12 | GOLDMAN SACHS GROUP INC | LIGAND PHARMACEUTICALS INC | 1,181,931 | 6.8% | EDGAR |